01406 CLARITY MEDICAL
- 0.520
- -0.010-1.89%
CLARITY MEDICAL News
Shushintang acquires 15 million shares of Clear Medical
Xiushentang (08200) announced that on April 8, 2024, the Group acquired a total of 15 million shares of the target company through intra-market transactions carried out on the Stock Exchange at a total cost of about HK$8.95 million (not including transaction costs), which is equivalent to approximately HK$0.60 per share. During the 12-month period prior to the date of the target company's acquisition, the group acquired a total of 1.3 million shares of the target company at a total cost of approximately HK$923,900 (not including transaction costs). The target company is Clarity Medical Group Holdings Limited (01406). Following the acquisition of the target company, the group merged
Xiushentang (08200.HK) acquired 15 million shares of Clarity Medical Group Holdings at a cost of approximately HK$8.95 million
Gelonghui, April 8, 丨 Xiushentang (08200.HK) announced that on April 8, 2024, the Group acquired a total of 15 million shares of the target company (Clarity Medical Group Holdings Limited) at a total cost of about HK$8.95 million (not including transaction costs) through in-market transactions carried out on the Stock Exchange, which is equivalent to approximately HK$0.60 per share. During the 12-month period prior to the date of the target company's acquisition, the Group acquired a total of 1.3 million shares of the target company at a total cost of approximately HK$923,900 (not including transaction costs). After the acquisition of the target company, the Group held a total of 1,630
This Insider Has Just Sold Shares In Clarity Medical Group Holding
We'd be surprised if Clarity Medical Group Holding Limited (HKG:1406) shareholders haven't noticed that the Executive Director, Wai Ip Tse, recently sold HK$2.0m worth of stock at HK$0.61 per share.
清晰醫療：二零二三/二四年中期報告
Don't Ignore The Insider Selling In Clarity Medical Group Holding
Anyone interested in Clarity Medical Group Holding Limited (HKG:1406) should probably be aware that the Executive Director, Wai Ip Tse, recently divested HK$2.0m worth of shares in the company, at an
CLARITY MEDICAL: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Clear Healthcare (01406.HK) plans to hold a board meeting on November 28 to approve interim results
On November 13, Gelonghui Healthcare (01406.HK) announced that the board of directors will hold a board meeting on November 28, 2023 (Tuesday) to (including) approve the interim results of the company and its subsidiaries for the six-month period ending September 30, 2023 and a proposal to consider the payment of interim dividends (if any).
Clarity Arm Saintford Hires Contractor for Renovation of TMT Medical Centre
Clarity Medical Group Holding (HKG:1406) said indirect, wholly-owned subsidiary Saintford has awarded a HK$525,338 contract to Wing Keung Contracting and Engineering, mandating the contractor to renov
Clarity Medical to Swing to April-September Loss
Clarity Medical (HKG:1406) expects a net loss of up to HK$24 million for the six months ended Sept. 30, as compared to a net profit of HK$7.9 million during the year-ago period. The anticipated turnar
CLARITY MEDICAL: Annual Report 2023
Clear Healthcare awarded a total of 354562 million reward shares
Clear Healthcare (01406) announced that on July 4, 2023, the company awarded rewards to a number of eligible participants (i.e. grantees) under the share reward program, involving a total of 354.5562 million reward shares. The purpose of awarding rewards is to align the interests of the grantor with those of the Group through share ownership, dividends and other allocations of share payments and/or enhancement of the value of the shares, to recognize the grantor's contributions, and to incentivize the long-term investment of the underwriter, thereby promoting the sustainable development of the Group.
Clear Healthcare (01406) awarded a total of 35.4562 million reward shares
According to the Zhitong Finance App, Clear Healthcare (01406) announced that on July 4, 2023, the company awarded rewards to a number of eligible participants (i.e. grantees) in accordance with the share reward plan, involving a total of 354.5562 million reward shares. The purpose of awarding rewards is to align the interests of the grantor with those of the Group through share ownership, dividends and other allocations of share payments and/or enhancement of the value of the shares, to recognize the grantor's contributions, and to incentivize the long-term investment of the underwriter, thereby promoting the sustainable development of the Group.
Express News | Clarity Medical Incurs Attributable Loss in Fiscal Year 2023
CLARITY MEDICAL: (I) ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023; AND (II) TERMINATION OF SHARE OPTION SCHEME
CLARITY MEDICAL: DATE OF BOARD MEETING
Clarity Medical to Swing to FY23 Loss
Clarity Medical Group (HKG:1406) expects a pre-tax loss of between HK$4.9 million and HK$5.4 million for the year ended March 31, as compared to an adjusted pre-tax profit of HK$37.2 million a year ea
CLARITY MEDICAL: PROFIT WARNING
Insider Buys Additional HK$589k In Clarity Medical Group Holding Stock \
Whilst it may not be a huge deal, we thought it was good to see that the Clarity Medical Group Holding Limited (HKG:1406) Executive Director, Wai Ip Tse, recently bought HK$589k worth of stock, for HK
Clarity Medical Group to Provide Funds for Trustee for On-Market Share Purchase; Shares Climb 5%
01:54 AM EST, 01/18/2023 (MT Newswires) -- Clarity Medical Group (HKG:1406) will provide funds for the professional trustee of its share award plan, Tricor Trust (Hong Kong), to purchase shares of the
Clear Healthcare: 2022/23 Interim Report
Analysis
Price Target
No Data
